GENINUS Inc. is a bioinformation analysis company that researches, develops, manufactures, and sells genome analysis solutions in South Korea, the United States, and Asia. Its offerings include target and biomarker discovery, AI digital pathology, single-cell analysis, and spatial and in-situ transcriptomics services, as well as SPACEINSIGHT, a cloud-based integrated analysis platform. The company serves hospitals, pharmaceutical companies, and researchers. GENINUS was founded in 2018 and is headquartered in Seoul, South Korea.